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Multidrug-resistant KB-VI cells carry amplified mdrl gene sequences located in an extrachromosomal compartment (on episomes). Since episomes 
do not contain centromeric or telomeric sequences it is unclear whether they are able to bind to nuclear matrix proteins that may regulate pisomal 
gene expression. Using high salt treatments followed by in situ hybridization and dot blot analyses we found evidence for direct binding of episomal 
DNA to nuclear matrix proteins. This binding could only be reversed after incubation with trypsin or proteinase K as determined by contour- 
clamped homogeneous electric field (CHEF) electrophoresis. Our findings are consistent with the concept that circular extrachromosomal DNA 
may not only reintegrate into nuclear DNA but may also be subject to functional control by regulatory proteins within the nuclear matrix. 
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1. INTRODUCTION 
Gene amplification has been reported for a variety of 
human neoplasms. Amplified DNA sequences may not 
only be found as part of chromosomal DNA but may 
also be present as elements of submicroscopic ircular 
extrachromosomal DNA (episomes) or microscopically 
visible double minutes [1,2]. It has been proposed that 
submicroscpic episomal sequences are derived from nu- 
clear DNA by deletion events that are induced by vari- 
ous forms of molecular stress [3]. After several amplifi- 
cation steps they may multimerize into extrachromo- 
somally located double minutes [4,5]. It has also been 
proposed that double minutes are capable of reintegra- 
tion into chromosomal DNA forming homogeneously 
staining regions [5-71. 
Eukaryotic cells contain non-histone proteins that 
form an insoluble skeletal framework of the nucleus 
[S-lo]. Using appropriate experimental conditions, in- 
tact loops of supercoiled eukaryotic DNA can be visual- 
ized as a halo surrounding these nuclear matrix proteins 
[l 11. The intimate contact of DNA with its nuclear ma- 
trix may serve an organizational purpose. In addition, 
the nuclear matrix has also been reported to be involved 
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in DNA replication and transcription [8]. There is evi- 
dence that the active site of replication requires attach- 
ment to nuclear matrix proteins [12]. 
Vinblastine-resistant human KB-Vl cells contain am- 
plified mdrl gene sequences of approximately 750 kb as 
circular supercoiled episomes [ 13,141. Overexpression of 
this gene results in resistance to a large group of lipo- 
philic agents including anthracyclines and vinca alka- 
loids [ 151. Multidrug-resistant KB-VI cells that contain 
a large number of episomes have been reported to divide 
more slowly than the drug-sensitive parent line without 
episomes uggesting that the presence of episomes may 
increase cell cycling time [16]. 
In the current study, we have investigated the possi- 
bility that episomal DNA sequences bind to nuclear 
matrix proteins, a prerequisite for a possible functional 
interference with replication-controlling units. The KB- 
VI model was chosen because it has been useful in a 
number of studies of mdrl gene amplification and ex- 
pression and mdrl sequences can conveniently be used 
as marker for amplified episomal DNA. 
2. MATERIALS AND METHODS 
2.1. Cells 
Vinblastine-resistant KB-VI cells and their drug-sensitive parent 
line KB3-1 were cultivated in Dulbeccos’s modified Eagle medium 
(DMEM) supplemented with 10% fetal calf serum, 200 mM glutam- 
ine, 2000 U/ml penicilhnktreptomycin. KB-Vl cells were grown in the 
presence of vinblastine (1 pg/ml) and contain amplified copies of mdrl 
on episomal DNA. KB331 cells do not contain amplified copies of 
mdrl. 
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Fig. 1. Production of DNA halos in isolated nuclei of KB-Vl cells. A, fluorescence microscopy-controls with low salt concentration. B, flourescence 
microscopy ~ treatment with 2 M NaCl. Note flourescent halo around nuclei. C, Giemsa stain - controls with low salt concentration. D, Giemsa 
stain treatment with 2 M NaCI. E, Methyl green stain -controls with low salt concentration. F, Methyl green stain - treatment with 2 M NaCl. 
Note that at low salt concentrations nuclear matrix and DNA are intimately associated. Treatment with 2 M NaCl induced stretching of supercoiled 
DNA loops to form halos surrounding the nuclear matrix (arrows). In some cells nucleolar remnants are visualised within the amorphous appearing 
nuclear matrix. Bar: 4.5 pm. 
2.2. Halo preparation 
Preparation of DNA halos was performed as published by Vogel- 
stein et al. with several modifications [l I]. Briefly, nuclei were isolated 
using 50 mM HEPES, 10 mM MgCl,, 0.5 mM CaCI,, 0.22 M sucrose, 
0.5% NP40 and transferred mto IO mM Tris containing 0.2 mM 
MgCI,. Separation of nuclear matrix and DNA was achieved by add- 
ing 10 mM Tris, 0.2 mM MgCI,, 2 M NaCI. After addition of 2 ~1 
ethidium bromide (10 mg/ml) an aliquot was examined using a Leitz 
fluorescence microscope. Another aliquot was irradiated with UV 
light (lo6 Jcm-*) using a Stratagen UV Stratalinker 2400. Halo prepa- 
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Fig. 2. In situ hybridization of nuclei from KB-VI and KB3-1 cells after treatment with 2 M NaCl. Hybridization was performed with a biotinylated 
MP64MDRl probe after RNAase digestion followed by a two-step gold method using a goat anti-biotin antibody-l nm gold complex. The signal 
was amplified (x 4) with silver. A, nuclei from mdr-1 positive KB-Vl cells. Note intense labeling of nuclear matrix (arrows). B, nuclei from mdr-1 
positive KB-VI cells after treatment with DNase. Note the absence of label. C, nuclei from mdrl-negative KB3-1 cells. Note the absence of label. 
rations were made from both irradiated and unirradiated samples. 
Aliquots of the preparations were further processed for staining 
(Giemsa, Methyl green) and for m situ hybridization using standard 
techniques [17]. 
2.3. In situ hybrrdization and peroxidase reaction 
The MP64MDRl probe was prepared using a kit from QIAGEN 
Inc. (Chatsworth, CA) and was labeled with biotinylated UTP using 
a kit from Boehringer Mannheim Co. (Indianapolis, IN). After incu- 
bation with RNase (25,000 U/mg, 100 @ml) or DNase (2 000 U/ml, 
20 ~1) the slides were immersed in 70% formamide, 2 x SSC (7O”C, 10 
min) and rapidly cooled on ice. Ten microliters of hybridization mix- 
ture was placed on each slide, covered with a plastic cover slip and 
incubated over night in a moist chamber at 37°C. The slides were then 
washed six times in 50% formamide/ x SSC, 3 times 2 x SSC followed 
by phosphate-buffered saline, pH 7.2. The peroxidase reaction was 
carried out using Streptavidin-Peroxidase (Jackson Immunoresearch, 
West Grove, PA; 2 ,ug/ml. 30 min). After removal of the complex, the 
slides were incubated for 10 min with diaminobenzidine and HzOz and 
stained with Methyl green. 
2.4. Colloidal gold and silver ampliJication 
Slides were incubated with 20 &ml goat-gold complex anti-biotin 
(Goldmark, Phillipsburg,NJ) in PBS/IO% BSA for 4 h. After removal 
of the gold complex, the slides were fixed in 3.7% formaldehyde/PBS. 
Signal enhancement was achieved with a silver enhancer kit from 
Goldmark. 
2.5. DNA extraction, dot blot analysis, and CHEF electrophoresis 
DNA extraction and dot blotting was done using standard tech- 
niques. Contour-clamped homogeneous electric field (CHEF) electro- 
phoresis was performed as described earlier [4]. Experimental condi- 
tions were chosen for optimal resolution in the range of 200-2000 kbp. 
After staining with ethidium bromide the gels were photographed and 
blotted on nylon membranes for Southern blot hybridization with the 
MP64MDRl probe. For controls, rehybridization was performed 
with pl lA2 (kindly provided by Dr. G. Wahl, San Diego, CA) and 
with MP64MDRl after preincubation of the CHEF gel blots with 
RNase ( 100 @ml). 
3. RESULTS 
Production of DNA halos was accomplished by ex- 
posing the nuclei preparation of KB-Vl cells to increas- 
ing concentrations of NaCl. This treatment forced 
DNA loops to stretch outside the nuclear matrix. As 
shown in Fig. 1 A-F, fluorescence micrsocopy, as well 
as Giemsa and Methyl green stains, of cell nuclei re- 
vealed halos that contain filamentous material repre- 
senting DNA while the nuclear matrix appears as more 
amorphous material in the stained preparations. Some 
nucleolar remnants were noted inside the matrix with 
more intensive staining. The same result was obtained 
when the nuclei were either incubated with ethidium 
bromide followed by flourescence microscopy or when 
methyl green was used for DNA staining. In situ hybrid- 
ization with MP64MDRl followed by amplification of 
the signal with colloidal gold and silver enhancement 
showed binding of the label to the nuclear matrix (Fig. 
2). Incubation with RNAase prior to hybridization de- 
creased the signal intensity indicating that some of the 
mdrl sequences were present within the RNA pool. No 
labeling was observed in drug-sensitive KB3-1 cells that 
lack the mdrl gene. Labeling was abolished by pretreat- 
ment with DNase. 
Total DNA was extracted from matrix pellets and 
from intact nuclei with or without pretreatment with 2 
M NaCl, in an attempt to further provide evidence for 
binding of episomal DNA to nuclear matrix proteins. 
No DNA was found in the supernatant. Probing with 
MP64MDRl showed that pretreatment with 2 M NaCl 
did not influence the amount of mdrl sequences de- 
tected (Fig. 3). Densitometry of dot blots gave the fol- 
lowing MP64MDRl/pl lA2 average ratios: Control: 
2.61 * 0.82, 2 M NaCl-treatment: 2.31 ? 0.54. CHEF 
electrophoresis was performed on KB-Vl and KB3-1 
cells using a resolution range of 200-2000 kbp. As 
shown in Fig. 4, pretreatment with proteinase K or 
trypsin was required to release pisomes into the gel and 
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(1,3) HIGH SALT PROCEDURE 
(2) CONTROL LOW SALT PROCEDURE 
Fig. 3. Dot blots of DNA extracts form KB-VI and KB3-1 cells after 
treatment with 2 M NaCl using MP64MDRl and Pl lA2 probes. The 
amount of mdrl sequences detected was not decreased after exposure 
to 2 M NaCl suggesting that episomal DNA may be bound to nuclear 
matrix protems. 
to generate bands at 560 kbp and 7.50 kbp. Exposure to 
gamma-irradiation was ineffective. RNase digestion 
prior to reprobing yielded identical bands. Reprobing 
with pl lA2 was negative. This result further supports 
the notion that episomal DNA sequences may bind to 
nuclear matrix proteins. 
4. DISCUSSION 
Replication and transcription of chromosomal DNA 
has been reported to be associated with binding of DNA 
to nuclear matrix proteins [12,18]. These observations 
have led to the hypothesis that the nuclear matrix may 
have a role in the regulation of replication or transcrip- 
tion. Episomes are submicroscopic circular pieces of 
extrachromosomal DNA within the nucleus that may 
carry amplified oncogenes and multidrug-resistance 
genes. Episomes are devoid of centromeric or telomeric 
sequences that are required for binding of chromosomal 
DNA to the nuclear matrix. It has therefore been un- 
clear whether episomes can bind to matrix proteins and 
how replication or transcription of episomal DNA se- 
quences is regulated. 
We now present evidence for binding of episomes that 
carry amplified mdrl sequences in KB-Vl epidermoid 
cancer cells to nuclear matrix proteins. The MDR l/KB- 
Vl system was chosen since MDRl is a convenient 
marker for episomal DNA and the drug-sensitive pa- 
rental cell lines KB331 can be used for controls. Our 
first experiment was performed under the assumption 
that forcing nuclear DNA loops outside the nuclear 
matrix by treatment with 2 M NaCl will solubilize 
smaller pieces of DNA not tightly attached to the ma- 
trix. We were unable to find any episomal DNA in the 
supernatant of our preparations indicating that most if 
not all extrachromosomal DNA is attached to the nu- 
clear matrix. Detection of MDRl sequences that remain 
attached to the nuclear matrix was achieved using silver 
amplification of the hybridization signal after RNase 
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treatment. Potential limitations of this approach are 
that some MDRl sequences might have been reinte- 
grated into chromosomal DNA as homogenously stain- 
ing regions or that extrachromosomal DNA might have 
been non-specifically trapped by the excess amount of 
chromosomal DNA. To address this possibility dot 
blotting experiments were performed on nuclear prepa- 
rations with or without pretreatment with 2 M NaCl 
and on MDRI-negative KB3-1 nuclei. These experi- 
ments indicate that no significant loss of MDRl se- 
quences occurs. In addition, CHEF electrophoresis 
demonstrated that episomal DNA sequences hybridiz- 
ing with the MDRl probe were only released after pro- 
tease digestion of the nuclear matrix. However, some of 
the episomal sequences remained within the agarose 
blocks and failed to migrate into the gel even after pro- 
tease treatment. The reason for this observation is not 
clear but may include trapping of episomal DNA by 
genomic DNA. Also, the size of some episomes may 
have been beyond the resolution of the CHEF electro- 
phoresis. Thirdly, if incorporation of MDRl sequences 
KBVl KB3.1 CONTROLS 
123 4 5 6 
- 1140kb 
- 750kb 
- 560kb 
MDRl PROBING 
1.2.3.5 PROTEASE DIGESTION 
4.6 NO DIGESTION CONTROLS 
Fig. 4. Southern blots of CHEF electrophoresis using KB-Vl and 
KB3-1 cells. Hybridization was performed usmg the MP64MDRl 
probe. Pretreatment with proteases was required to release eptsomal 
DNA sequences into the gel whereas gamma-irradtatlon alone was 
meffecttve. Lane 1. KB-Vl cells pretreatment wtth proteinase K and 
gamma-irradiation; lane 2, KB-VI cells pretreatment with pro- 
teinase K: lane 3. KB-Vl cells pretreatment with trypsin. lane 4, 
KB-VI cells pretreatment wnh gamma-irradtation; lane 5. KB3-1 
cells pretreatment with proteinase K and gamma-nradiation; lane 
6. KB3-1 ceils pretreatment with gamma-irradiation. 
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into chromosomal DNA had occurred, migration into 
the gel would not be possible. 
In summary, we have provided evidence that epi- 
somal DNA may bind to nuclear matrix proteins. Fu- 
ture research will be required to address the specificity 
and functional significance of this association. Recent 
evidence suggest that presence of episomal DNA may 
increase cell cycling time and thus may slow tumor 
growth in vitro [16]. It is tempting to hypothesize that 
this may be the result of interference (by episomal 
DNA) with the orderly progression of replication of 
chromosomal DNA in vitro. By binding to sites within 
the nuclear matrix that are involved in the regulation of 
transcription and/or replication episomal DNA may 
compete with genomic DNA for further processing. 
This concept would predict increased cell cycling times 
in cells that carry extrachromosomal DNA. Identifica- 
tion of the exact binding sites could be important for the 
development of new therapeutic agents. 
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